News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
755,545 Results
Type
Article (53861)
Company Profile (380)
Press Release (701304)
Multimedia
Podcasts (121)
Webinars (14)
Section
Business (217540)
Career Advice (2891)
Deals (38046)
Drug Delivery (127)
Drug Development (86859)
Employer Resources (177)
FDA (17456)
Job Trends (15965)
News (370452)
Policy (35612)
Tag
Academia (2691)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (88)
Alliances (54535)
ALS (100)
Alzheimer's disease (1487)
Antibody-drug conjugate (ADC) (158)
Approvals (17418)
Artificial intelligence (308)
Autoimmune disease (29)
Automation (16)
Bankruptcy (381)
Best Places to Work (11941)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (242)
Bladder cancer (85)
Brain cancer (30)
Breast cancer (297)
Cancer (2413)
Cardiovascular disease (202)
Career advice (2433)
Career pathing (34)
CAR-T (174)
Cell therapy (488)
Cervical cancer (21)
Clinical research (70538)
Collaboration (918)
Company closure (1)
Compensation (571)
Complete response letters (29)
COVID-19 (2792)
CRISPR (49)
C-suite (271)
Cystic fibrosis (106)
Data (2293)
Decentralized trials (2)
Denatured (38)
Depression (55)
Diabetes (293)
Diagnostics (6548)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (131)
Drug pricing (128)
Drug shortages (32)
Duchenne muscular dystrophy (103)
Earnings (88816)
Editorial (45)
Employer branding (22)
Employer resources (155)
Events (120478)
Executive appointments (775)
FDA (18827)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (807)
Gene editing (122)
Generative AI (27)
Gene therapy (355)
GLP-1 (848)
Government (4439)
Grass and pollen (6)
Guidances (106)
Healthcare (18942)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (29)
Infectious disease (2954)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (102)
Interviews (526)
IPO (17208)
IRA (51)
Job creations (4469)
Job search strategy (2044)
Kidney cancer (11)
Labor market (40)
Layoffs (546)
Leadership (24)
Legal (8867)
Liver cancer (80)
Lung cancer (340)
Lymphoma (158)
Machine learning (8)
Management (62)
Manufacturing (360)
MASH (78)
Medical device (13840)
Medtech (13845)
Mergers & acquisitions (21410)
Metabolic disorders (791)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2091)
NextGen: Class of 2025 (6904)
Non-profit (4312)
Now hiring (40)
Obesity (430)
Opinion (269)
Ovarian cancer (80)
Pain (102)
Pancreatic cancer (88)
Parkinson's disease (161)
Partnered (22)
Patents (255)
Patient recruitment (119)
Peanut (48)
People (61969)
Pharmaceutical (111)
Pharmacy benefit managers (22)
Phase I (21865)
Phase II (30858)
Phase III (23348)
Pipeline (1327)
Policy (177)
Postmarket research (2911)
Preclinical (9265)
Press Release (70)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (265)
Rare diseases (426)
Real estate (6769)
Recruiting (68)
Regulatory (24634)
Reports (43)
Research institute (2459)
Resumes & cover letters (454)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (82)
Series A (143)
Series B (94)
Service/supplier (20)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (160)
Sponsored (33)
Startups (4016)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (51)
The Weekly (81)
Vaccines (808)
Venture capitalists (44)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (304)
Last 7 days (890)
Last 30 days (3039)
Last 365 days (34332)
2025 (12005)
2024 (36896)
2023 (41668)
2022 (52762)
2021 (57291)
2020 (55713)
2019 (48195)
2018 (36489)
2017 (34979)
2016 (35412)
2015 (41029)
2014 (35597)
2013 (30187)
2012 (32168)
2011 (32479)
2010 (31105)
Location
Africa (934)
Alabama (60)
Alaska (7)
Arizona (258)
Arkansas (13)
Asia (45219)
Australia (7340)
California (6425)
Canada (2042)
China (564)
Colorado (278)
Connecticut (299)
Delaware (161)
Europe (102034)
Florida (945)
Georgia (218)
Hawaii (1)
Idaho (64)
Illinois (601)
India (28)
Indiana (333)
Iowa (11)
Japan (172)
Kansas (105)
Kentucky (26)
Louisiana (12)
Maine (68)
Maryland (963)
Massachusetts (4900)
Michigan (242)
Minnesota (412)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (65)
New Jersey (1821)
New Mexico (30)
New York (1812)
North Carolina (1083)
North Dakota (9)
Northern California (2787)
Ohio (211)
Oklahoma (12)
Oregon (39)
Pennsylvania (1400)
Puerto Rico (13)
Rhode Island (34)
South America (1359)
South Carolina (26)
South Dakota (1)
Southern California (2408)
Tennessee (104)
Texas (948)
United States (24480)
Utah (185)
Virginia (164)
Washington D.C. (70)
Washington State (575)
West Virginia (3)
Wisconsin (67)
755,545 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Press Releases
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
March 18, 2025
·
3 min read
Deals
Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.
October 2, 2023
·
4 min read
Business
Deep Dive: JPM M&A Rush Just the Start, as Biopharma Insider Predicts Mega-Deals to Come
The J.P. Morgan Healthcare Conference started off with a flurry of deals that reinvigorated excitement across the biopharma industry. Johnson & Johnson moved to acquire Intra-Cellular Therapies for $14.6 billion, breaking a dealmaking barrier that kept Big Pharma’s 2024 biotech buyouts to under $5 billion.
January 29, 2025
·
1 min read
·
Annalee Armstrong
Manufacturing
Biopharma’s Big Question of 2024: Can You Scale It?
Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of pharma is going to be vying for capacity and talent.
December 18, 2024
·
5 min read
·
Annalee Armstrong
Policy
Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze
As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.
April 11, 2025
·
3 min read
·
BioSpace Editorial Staff
Editorial
The People Behind Biopharma’s Big Wins: Personal Stories From JPM25
As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and pharma executives—and the general comradery in the air throughout the chaotic event.
January 17, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
BIO-Europe Spring 2025: Partnering is Surging - All Roads Lead to Milan for Biopharma’s Premier Springtime Event
March 10, 2025
·
5 min read
Press Releases
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
May 1, 2025
·
3 min read
Tariffs
Biotech’s ‘Nauseating Roller Coaster’ Repels Investors
Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty sent fresh shockwaves through an already fragile market.
April 23, 2025
·
5 min read
·
Ana Mulero
1 of 75,555
Next
